The store will not work correctly when cookies are disabled.
1-Benzylpiperidin-4-yl benzoate
ID: ALA4083390
PubChem CID: 15124790
Max Phase: Preclinical
Molecular Formula: C19H21NO2
Molecular Weight: 295.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(OC1CCN(Cc2ccccc2)CC1)c1ccccc1
Standard InChI: InChI=1S/C19H21NO2/c21-19(17-9-5-2-6-10-17)22-18-11-13-20(14-12-18)15-16-7-3-1-4-8-16/h1-10,18H,11-15H2
Standard InChI Key: SBQQIGHODWKFKK-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
24.2524 -12.9105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9627 -12.4992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6761 -12.9051 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9596 -11.6779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3863 -12.4939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0942 -12.9025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8024 -12.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8035 -11.6730 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0903 -11.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3801 -11.6744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5154 -11.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2272 -11.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2221 -12.4942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9331 -12.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6460 -12.4941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6433 -11.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9318 -11.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5403 -12.5012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8305 -12.9117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8331 -13.7339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5515 -14.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2584 -13.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
1 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 1 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.38 | Molecular Weight (Monoisotopic): 295.1572 | AlogP: 3.51 | #Rotatable Bonds: 4 |
Polar Surface Area: 29.54 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.67 | CX LogP: 3.73 | CX LogD: 2.44 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -0.58 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |